Evidence map›Paper›PMID 29044173›Full record

ArticleScientific reports2017

Palmitate-induced lipotoxicity alters acetylation of multiple proteins in clonal β cells and human pancreatic islets.

Federica Ciregia, Marco Bugliani, Maurizio Ronci, Laura Giusti, Claudia Boldrini, Maria R Mazzoni, Sandra Mossuto, Francesca Grano, Miriam Cnop, Lorella Marselli and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Federica CiregiaDepartment of Pharmacy, University of Pisa; Via Bonanno 6, 56126, Pisa, Italy.
Marco BuglianiDepartment of Clinical and Experimental Medicine, Islet Cell Laboratory, Via Savi 10, 56126, Pisa, Italy.ORCID 0000-0002-1744-1561
Maurizio RonciProteomics and Metabonomics Unit, IRCCS-Fondazione Santa Lucia; Via del Fosso di Fiorano 64/65, 00143, Rome, Italy.
Laura GiustiDepartment of Pharmacy, University of Pisa; Via Bonanno 6, 56126, Pisa, Italy. laura.giusti@farm.unipi.it.ORCID 0000-0001-7366-1932
Claudia BoldriniDepartment of Pharmacy, University of Pisa; Via Bonanno 6, 56126, Pisa, Italy.
Maria R MazzoniDepartment of Pharmacy, University of Pisa; Via Bonanno 6, 56126, Pisa, Italy.
Sandra MossutoDepartment of Clinical and Experimental Medicine, Islet Cell Laboratory, Via Savi 10, 56126, Pisa, Italy.
Francesca GranoDepartment of Clinical and Experimental Medicine, Islet Cell Laboratory, Via Savi 10, 56126, Pisa, Italy.
Miriam CnopULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels, Belgium.ORCID 0000-0002-5112-1692
Lorella MarselliDepartment of Clinical and Experimental Medicine, Islet Cell Laboratory, Via Savi 10, 56126, Pisa, Italy.ORCID 0000-0002-6698-2962
Gino GiannacciniDepartment of Pharmacy, University of Pisa; Via Bonanno 6, 56126, Pisa, Italy.
Andrea UrbaniProteomics and Metabonomics Unit, IRCCS-Fondazione Santa Lucia; Via del Fosso di Fiorano 64/65, 00143, Rome, Italy.
Antonio LucacchiniDepartment of Pharmacy, University of Pisa; Via Bonanno 6, 56126, Pisa, Italy.
Piero MarchettiDepartment of Clinical and Experimental Medicine, Islet Cell Laboratory, Via Savi 10, 56126, Pisa, Italy.
University of Pisa · ITUniversità Cattolica del Sacro Cuore · ITUniversité Libre de Bruxelles · BEUniversity of Chieti-Pescara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes is characterized by progressive β cell dysfunction, with lipotoxicity playing a possible pathogenetic role. Palmitate is often used to examine the direct effects of lipotoxicity and it may cause mitochondrial alterations by activating protein acetylation. However, it is unknown whether palmitate influences protein acetylation in β cells. We investigated lysine acetylation in mitochondrial proteins from INS-1E β cells (INS-1E) and in proteins from human pancreatic islets (HPI) after 24 h palmitate exposure. First, we confirmed that palmitate damages β cells and demonstrated that chemical inhibition of deacetylation also impairs INS-1E function and survival. Then, by 2-D gel electrophoresis, Western Blot and Liquid Chromatography-Mass Spectrometry we evaluated the effects of palmitate on protein acetylation. In mitochondrial preparations from palmitate-treated INS-1E, 32 acetylated spots were detected, with 13 proteins resulting over-acetylated. In HPI, 136 acetylated proteins were found, of which 11 were over-acetylated upon culture with palmitate. Interestingly, three proteins, glutamate dehydrogenase, mitochondrial superoxide dismutase, and SREBP-1, were over-acetylated in both INS-1E and HPI. Therefore, prolonged exposure to palmitate induces changes in β cell protein lysine acetylation and this modification could play a role in causing β cell damage. Dysregulated acetylation may be a target to counteract palmitate-induced β cell lipotoxicity.

Indexed as

AcetylationCell SurvivalGlucoseHumansInsulin-Secreting CellsIslets of LangerhansMitochondriaPalmitatesProtein Processing, Post-TranslationalGlucosePalmitates

Identifiers

PMID29044173
PMCPMC5647430
OpenAlexW2760903239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.